D. Nelson

发表

Synthesis and biological activity of some known and putative duloxetine metabolites.

T. Gillespie, F. Kuo, P. Kulanthaivel, 2004, Bioorganic & medicinal chemistry letters.

Three-dimensional quantitative structure-activity relationships of 5-HT receptor binding data for tetrahydropyridinylindole derivatives: a comparison of the Hansch and CoMFA methods.

J. Regan, D. Nelson, A. Agarwal, 1993, Journal of medicinal chemistry.

Altered leukocyte response to CXCL12 in patients with warts hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome.

L. Notarangelo, R. Badolato, S. Sozzani, 2004, Blood.

Neurogenic Dural Protein Extravasation Induced by Meta-Chlorophenylpiperazine (Mcpp) Involves Nitric Oxide and 5-HT2B Receptor Activation

D. Nelson, J. Audia, L. Phebus, 2003, Cephalalgia : an international journal of headache.

Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat: A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder

K. Perry, F. Bymaster, S. Hemrick-Luecke, 2002, Neuropsychopharmacology.

Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.

D. Nelson, R. Yarchoan, W. Biddison, 1985, Journal of immunology.

The Phenomenon of Spontaneous Genetic Reversions in the Wiskott-Aldrich Syndrome: A Report of the Workshop of the ESID Genetics Working Party at the XIIth Meeting of the European Society for Immunodeficiencies (ESID). Budapest, Hungary October 4–7, 2006

F. Candotti, D. Nelson, D. Stewart, 2007, Journal of Clinical Immunology.

Retrovirus-mediated WASP gene transfer corrects Wiskott-Aldrich syndrome T-cell dysfunction.

F. Candotti, D. Nelson, G. Jagadeesh, 2002, Human gene therapy.

Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy.

W. Blattner, T. Waldmann, E. Murphy, 1990, Proceedings of the National Academy of Sciences of the United States of America.

The cloning and sequence analysis of the rat serotonin-1A receptor gene.

H. Yamamura, D. Nelson, E. Varga, 1990, Life sciences.

HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Regulation and Function of WASp in Platelets by the Collagen Receptor, Glycoprotein VI

S. Watson, D. Nelson, H. Chapel, 1999 .

HEMOSTASIS , THROMBOSIS , AND VASCULAR BIOLOGY Regulation and Function of WASp in Platelets by the Collagen Receptor , Glycoprotein

S. Watson, D. Nelson, H. Chapel, 1999 .

Hypogammaglobulinemia, Infections, Myelokathexis (WHIM) syndrome Altered leukocyte response to CXCL12 in patients with Warts

R. Badolato, S. Sozzani, D. Nelson, 2013 .

Preclinical pharmacological profile of the selective 5-HT1F receptor agonist lasmiditan

Kirk W. Johnson, D. Nelson, L. Phebus, 2010, Cephalalgia.

A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. II. Expression of Tac antigen on activated cytotoxic killer T cells, suppressor cells, and on one of two types of helper T cells.

T. Waldmann, D. Nelson, T. Fleisher, 1981, Journal of immunology.

Increased serum soluble interleukin-2 receptors in caucasian and Korean schizophrenic patients

S. Paul, Y. S. Kim, D. Pickar, 1994, Biological Psychiatry.

Multiple receptors for serotonin in the rat brain.

A. Herbet, J. Glowinski, M. Hamon, 1980, Advances in biochemical psychopharmacology.

Typical and Atypical Antipsychotic Drugs Increase Extracellular Histamine Levels in the Rat Medial Prefrontal Cortex: Contribution of Histamine H1 Receptor Blockade

K. Perry, D. Nelson, K. Svensson, 2012, Front. Psychiatry.

Limiting dilution analysis of Epstein-Barr virus-induced immunoglobulin production by human B cells

R. Blaese, D. Nelson, R. Yarchoan, 1983, The Journal of experimental medicine.

Preclinical Pharmacology of FMPD [6-Fluoro-10-[3-(2-methoxyethyl)-4-methyl-piperazin-1-yl]-2-methyl-4H-3-thia-4,9-diaza-benzo[f]azulene]: A Potential Novel Antipsychotic with Lower Histamine H1 Receptor Affinity Than Olanzapine

Todd R. Wiernicki, F. Bymaster, L. Nisenbaum, 2005, Journal of Pharmacology and Experimental Therapeutics.

The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine.

D. Wong, T. Branchek, J. Zgombick, 2000, The Journal of pharmacology and experimental therapeutics.

Dynamic changes in soluble interleukin-2 receptor levels after lung or heart-lung transplantation.

G. Noon, M. Debakey, D. Nelson, 1989, The American review of respiratory disease.

Defects of T-cell effector function and post-thymic maturation in X-linked hyper-IgM syndrome.

P. Lipsky, D. Nelson, W. Strober, 1999, The Journal of clinical investigation.

Possible application of flow cytometry for evaluation of the structure and functional status of WASP in peripheral blood mononuclear cells

M. Yamada, T. Ariga, Y. Sakiyama, 2009, European journal of haematology.

thrombocytopenia Missense mutations of the WASP gene cause intermittent X-linked

L. Notarangelo, H. Ochs, S. Giliani, 2013 .

correlation effect on transcription, and translation and phenotype/genotype Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots,

L. Notarangelo, H. Ochs, S. Giliani, 2011 .

Linking cellular activation to cytoskeletal reorganization: Wiskott–Aldrich syndrome as a model

D. Nelson, D. Stewart, L. Tian, 2001, Current opinion in allergy and clinical immunology.

Studies of the expression of the Wiskott-Aldrich syndrome protein.

L. Notarangelo, F. Facchetti, D. Nelson, 1996, The Journal of clinical investigation.

Constrictive pericarditis, intestinal lymphangiectasia, and reversible immunologic deficiency.

T. Waldmann, R. Blaese, D. Nelson, 1975, The Journal of pediatrics.

Pharmacologic Characterization of the Cloned Human Trace Amine-Associated Receptor1 (TAAR1) and Evidence for Species Differences with the Rat TAAR1

Y. Tu, D. Nelson, S. Little, 2007, Journal of Pharmacology and Experimental Therapeutics.

Multiple patients with revertant mosaicism in a single Wiskott-Aldrich syndrome family.

F. Candotti, S. Schurman, D. Nelson, 2004, Blood.

Species variations in transmembrane region V of the 5-hydroxytryptamine type 2A receptor alter the structure-activity relationship of certain ergolines and tryptamines.

R. Loncharich, D. Nelson, M. Baez, 1994, Molecular pharmacology.

N(1)-substituted ergolines and tryptamines show species differences for the agonist-labeled 5-HT2 receptor.

D. Nelson, J. Audia, M. P. Johnson, 1993, European journal of pharmacology.

Species differences in the pharmacology of the 5-hydroxytryptamine2 receptor: structurally specific differentiation by ergolines and tryptamines.

D. Nelson, J. Audia, D. Wainscott, 1993, The Journal of pharmacology and experimental therapeutics.

Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives.

D. E. Nichols, E. sanders-Bush, D. Nelson, 1997, Journal of medicinal chemistry.

Bronchoalveolar lavage analysis, gallium-67 lung scanning and soluble interleukin-2 receptor levels in asbestos exposure.

D. Nelson, G. Delclos, E. C. Lawrence, 1989, Environmental research.

Osteopenia in X-linked hyper-IgM syndrome reveals a regulatory role for CD40 ligand in osteoclastogenesis

E. López-Granados, D. Follmann, Shuying Liu, 2007, Proceedings of the National Academy of Sciences.

Tracking gene expression in primary immunodeficiencies

M. Yamada, D. Nelson, A. V. Gulino, 2003, Current opinion in allergy and clinical immunology.

Similarities and differences in 111In- and 90Y-labeled 1B4M-DTPA antiTac monoclonal antibody distribution.

T. Waldmann, M. Brechbiel, J. Carrasquillo, 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Role for Msh5 in the regulation of Ig class switch recombination

D. Altshuler, Annette Lee, P. Gregersen, 2007, Proceedings of the National Academy of Sciences.

Temporal variability in immunological parameters: Peripheral blood mononuclear cell subsets, serum immunoglobulins, and soluble markers of immune system activation

W. Blattner, L. Brown, D. Fuchs, 1997, Journal of clinical laboratory analysis (Print).

Radioimmunotherapy of Nude Mice Bearing a Human Interleukin 2 Receptor α-expressing Lymphoma Utilizing the α-emitting Radionuclide-conjugated Monoclonal Antibody 212Bi-anti-Tac

T. Waldmann, M. Brechbiel, K. Garmestani, 1994 .

Elevated soluble interleukin-2 receptor levels in the sera and synovial fluids of patients with rheumatoid arthritis.

C. Bombardier, C. -. Chang, E. Keystone, 1988, Arthritis and rheumatism.

The Sézary syndrome: a malignant proliferation of helper T cells.

T. Waldmann, R. Macdermott, S. Broder, 1976, The Journal of clinical investigation.

Increased serum soluble interleukin-2 receptors in schizophrenic monozygotic twins

S. Paul, E. Torrey, D. Pickar, 2005, European Archives of Psychiatry and Clinical Neuroscience.

Elevated serum levels of soluble Tac peptide in adult T-cell leukemia: correlation with clinical status during chemotherapy.

D. Longo, B. Edwards, D. Nelson, 1988, Annals of internal medicine.

The human interleukin-2 receptor: normal and abnormal expression in T cells and in leukemias induced by the human T-lymphotropic retroviruses.

T. Waldmann, W. Leonard, W. Greene, 1986, Annals of internal medicine.

Activated lymphocytes during acute Epstein-Barr virus infection.

D. Nelson, B. Tomkinson, J. Sullivan, 1987, Journal of immunology.

Soluble interleukin-2 receptor levels in patients with undifferentiated and lymphoblastic lymphomas: correlation with survival.

B. Edwards, I. Magrath, D. Nelson, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A monoclonal antibody 7G7/B6, binds to an epitope on the human interleukin-2 (IL-2) receptor that is distinct from that recognized by IL-2 or anti-Tac.

D. Nelson, W. Biddison, L. Rubin, 1985, Hybridoma.

WASP Interacting Protein Wiskott-Aldrich Syndrome Protein ( WASP ) Syndrome Impair the Interaction of Mutations That Cause the Wiskott-Aldrich

D. Nelson, D. Stewart, L. Tian, 1999 .

Specific anti-influenza virus antibody production in vitro by lymphocytes from a subset of patients with hypogammaglobulinemia.

D. Nelson, R. Yarchoan, B. Wray, 1983, The Journal of clinical investigation.

The Interleukin-2 Receptor : A Target for Monoclonal Antibody Treatment of Human Tc e l l Lymphotrophic Virus I-Induced Adult Tc e l l Leukemia

Elaine, T. Waldmann, B. Mishra, 2003 .

Serum neopterin, beta2-microglobulin, soluble interleukin-2 receptors, and immunoglobulin levels in healthy adolescents.

W. Blattner, L. Brown, D. Fuchs, 1998, Clinical immunology and immunopathology.

Racial differences in serum immunoglobulin levels: Relationship to cigarette smoking, t‐cell subsets, and soluble interleukin‐2 receptors

W. Blattner, R. Hoover, L. Brown, 1995, Journal of clinical laboratory analysis.

Soluble Tac peptide is present in the urine of normal individuals and at elevated levels in patients with adult T cell leukaemia (ATL).

D. Nelson, L. Marcon, C. Kurman, 1988, Clinical and experimental immunology.

Epitope Blocking: Positive and Negative Effects on the Biodistribution of 125I‐Labeled Anti‐Tac Disulfide‐stabilized Fv Fragment of Two Antibodies against Different Epitopes of the Circulating Antigen

T. Waldmann, I. Pastan, Hisataka Kobayashi, 1998, Japanese journal of cancer research : Gann.

Cytotoxic activities of gut mucosal lymphoid cells in guinea pigs.

J. Bienenstock, D. Nelson, F. Arnaud-Battandier, 1978, Journal of immunology.

Substituted furo[3,2-b]pyridines: novel bioisosteres of 5-HT 1F receptor agonists.

T. Branchek, J. Zgombick, W. Gough, 2004, Bioorganic & medicinal chemistry letters.

6.18 – Obesity/Disorders of Energy

D. Nelson, D. Gehlert, 2007 .

Central nervous system biogenic amine targets for control of appetite and energy expenditure

D. Nelson, D. Gehlert, 2006, Endocrine.

In vivo administration of purified human interleukin-2 to patients with cancer: development of interleukin-2 receptor positive cells and circulating soluble interleukin-2 receptors following interleukin-2 administration.

S. Rosenberg, M. Lotze, D. Nelson, 1987, Cancer research.

Lymphocyte analysis in a patient with X-linked agammaglobulinemia and isolated growth hormone deficiency after development of echovirus dermatomyositis and meningoencephalitis.

G. Marti, E. Jaffe, D. Nelson, 1989, International archives of allergy and applied immunology.

Virus specificity of human influenza virus-immune cytotoxic T cells.

D. Nelson, W. Biddison, S. Shaw, 1979, Journal of immunology.

IL-15 induces the release of soluble IL-2Ralpha from human peripheral blood mononuclear cells.

D. Nelson, C. Kurman, D. Stewart, 1996, Clinical immunology and immunopathology.

51Cr Release Assay of Antibody‐Dependent Cell‐Mediated Cytotoxicity (ADCC)

D. Nelson, C. Kurman, D. Serbousek, 1993, Current protocols in immunology.

Radioimmunotherapy of nude mice bearing a human interleukin 2 receptor alpha-expressing lymphoma utilizing the alpha-emitting radionuclide-conjugated monoclonal antibody 212Bi-anti-Tac.

M. Brechbiel, K. Garmestani, O. Gansow, 1994, Cancer research.

Soluble interleukin-2 receptor in juvenile rheumatoid arthritis.

E. Silverman, D. Nelson, R. Laxer, 1991, The Journal of rheumatology.

GULINO et al. LEUKOCYTE CHEMOTAXIS IN WHIM PATIENTS Regular Manuscript: IMMUNOBIOLOGY Altered leukocyte response to CXCL12 in patients with Warts

L. Notarangelo, R. Badolato, S. Sozzani, 2004 .

Expression of functional IL 2 receptors by lipopolysaccharide and interferon-gamma stimulated human monocytes.

T. Waldmann, W. Greene, C. Goldman, 1987, Journal of immunology.

Selective elimination in vitro of alloresponsive T cells to human transplantation antigens by toxin or radionuclide conjugated anti-IL-2 receptor (Tac) monoclonal antibody.

T. Waldmann, I. Pastan, C. Goldman, 1990, Journal of immunology.

Use of an antibody against the soluble interleukin 2 receptor alpha subunit can modulate the stability and biodistribution of interleukin-2.

T. Waldmann, I. Pastan, J. Carrasquillo, 1999, Cytokine.

[3H]LY334370, a novel radioligand for the 5-HT1F receptor. I. In vitro characterization of binding properties

J. Zgombick, J. Krushinski, D. Nelson, 2005, Naunyn-Schmiedeberg's Archives of Pharmacology.

A novel class of 5-HT2A receptor antagonists: aryl aminoguanidines.

D. Nelson, H. Bryant, M. Baez, 1996, Life sciences.

Flow cytometric analysis of Wiskott-Aldrich syndrome (WAS) protein in lymphocytes from WAS patients and their familial carriers.

M. Yamada, I. Kobayashi, T. Ariga, 1999, Blood.

The malignant B cells from B-chronic lymphocytic leukemia patients release TAC-soluble interleukin-2 receptors.

N. Kay, D. Nelson, J. Burton, 1988, Blood.

A MALIGNANT PROLIFERATION OF HELPER T CELLS

T. Waldmann, R. Macdermott, S. Broder, 1976 .

Cytotoxic effector cell function in organized gut-associated lymphoid tissue (GALT).

R. Blaese, D. Nelson, W. Strober, 1976, Cellular immunology.

Distribution of alloantigens on human Fc receptor-bearing lymphocytes: the presence of B cell alloantigens on sIg-positive but not sIg-negative lymphocytes.

D. Mann, D. Nelson, W. Strober, 1977, Journal of immunology.

Production of monoclonal antibodies to Bruton's tyrosine kinase.

D. Nelson, C. Kurman, D. Stewart, 1995, Hybridoma.

X-linked hypogammaglobulinemia and isolated growth hormone deficiency: an update

L. Notarangelo, D. Nelson, D. Stewart, 2007, Immunologic research.

Computer-assisted autoradiographic localization of subtypes of serotonin1 receptors in rat brain

H. Yamamura, D. Nelson, P. Deshmukh, 1983, Brain Research.

A competitive enzyme-linked immunoassay (ELISA) for the measurement of soluble human interleukin-2 receptors (IL-2R, Tac protein).

B. Cullen, A. Goldstein, D. Nelson, 1988, Journal of immunological methods.

Human T-cell subset requirements for the production of specific anti-influenza virus antibodyin vitro

D. Nelson, R. Yarchoan, W. Biddison, 1982, Journal of Clinical Immunology.

Killing of measles virus-infected cells by human cytotoxic T cells

D. Nelson, W. Biddison, S. Shaw, 1982, Infection and immunity.

Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hybrid molecules with unexpected muscarinic antagonist activity.

R. Mailman, D. Nelson, M. Lewis, 1998, Journal of medicinal chemistry.

( 3 H)Rauwolscine: an antagonist radioligand

D. Nelson, D. A. Sasso, M. Baez, 1998 .

[3H]Rauwolscine: an antagonist radioligand for the cloned human 5-hydroxytryptamine2B (5-HT2B) receptor

D. Nelson, D. A. Sasso, M. Baez, 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.

Synthesis and serotonin receptor binding properties of 5-substituted 3-(1′,2′,5′,6′-tetrahydropyridin-3′-yl) indoles

D. Nelson, H. B. Li, T. Dahlgren, 1995 .

Preclinical studies on LY237733, a potent and selective serotonergic antagonist.

R. Fuller, D. Nelson, D. Calligaro, 1992, The Journal of pharmacology and experimental therapeutics.

Effect of Cyclosporin on Interleukin 2–Related T-Lymphocyte Parameters in IDDM Patients

L. Chatenoud, C. Boitard, G. Feutren, 1989, Diabetes.

Studies of complement receptors on cytotoxic effector cells in human peripheral blood.

C. Steer, D. Nelson, E. Jones, 1978, Cellular Immunology.

AKAP350 interaction with cdc42 interacting protein 4 at the Golgi apparatus.

M. Larocca, R. Shanks, J. Goldenring, 2004, Molecular biology of the cell.

Distinct interactions of the X-linked lymphoproliferative syndrome gene product SAP with cytoplasmic domains of members of the CD2 receptor family.

L. Notarangelo, H. Ochs, C. Duckett, 2001, Clinical Immunology.

Elevated concentrations of soluble interleukin-2 receptors in serum samples and bronchoalveolar lavage fluids in active sarcoidosis.

D. Nelson, L. Marcon, C. Kurman, 1988, The American review of respiratory disease.

Gluten-sensitive enteropathy. Influence of histocompatibility type on gluten sensitivity in vitro.

A. Katz, D. Kasarda, D. Nelson, 1980, The Journal of clinical investigation.

Characterization of a soluble suppressor of human B cell immunoglobulin biosynthesis produced by a continuous human suppressor T cell line

T. Waldmann, W. Greene, C. Goldman, 1981, The Journal of experimental medicine.

HUMAN B CELL IMMUNOGLOBULIN BIOSYNTHESIS PRODUCED BY A CONTINUOUS HUMAN SUPPRESSOR T CELL LINE

W. Greene, T. Fleisher, C. Goldman, 1981 .

An analysis of the cellular requirements for the production of soluble interleukin-2 receptorsin vitro

D. Nelson, L. Rubin, C. Kurman, 1986, Journal of Clinical Immunology.

The molecular basis for the generation of the human soluble interleukin 2 receptor.

W. Greene, G. Jay, D. Nelson, 1990, Cytokine.

Soluble interleukin 2 receptors are elevated in patients with AIDS or at risk of developing AIDS.

D. Nelson, L. Miller, D. Blair, 1987, Clinical immunology and immunopathology.

Mutations of transmembrane IV and V serines indicate that all tryptamines do not bind to the rat 5-HT2A receptor in the same manner.

D. Nelson, M. Baez, V. Lucaites, 1997, Brain research. Molecular brain research.

Retrovirus-mediated WASP gene transfer corrects defective actin polymerization in B cell lines from Wiskott–Aldrich syndrome patients carrying ‘null’ mutations

F. Facchetti, F. Candotti, R. Blaese, 1999, Gene Therapy.

Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac.

T. Waldmann, E. Jaffe, M. Brechbiel, 1995, Blood.

Partial immune reconstitution of X-linked hyper IgM syndrome with recombinant CD40 ligand.

S. Pittaluga, H. Ochs, S. Migueles, 2011, Blood.

SPECIFIC B-CELL ANTIGENS ASSOCIATED WITH GLUTEN-SENSITIVE ENTEROPATHY AND DERMATITIS HERPETIFORMIS

D. Mann, D. Nelson, W. Strober, 1976, The Lancet.

An assessment of serum and urine soluble interleukin-2 receptor concentrations during renal transplant rejection.

D. Nelson, L. Patterson, G. Bock, 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Multiple subtypes of serotonin receptors are expressed in rat sensory neurons in culture.

J. Zgombick, M. Vasko, D. Nelson, 1998, The Journal of pharmacology and experimental therapeutics.

Synthesis and serotonin receptor affinities of a series of trans-2-(indol-3-yl)cyclopropylamine derivatives.

D. Nelson, S. Vangveravong, V. Lucaites, 1998, Journal of medicinal chemistry.

[3H]5‐Hydroxytryptamine Binding Sites: Species and Tissue Variation

R. Schnellmann, D. Nelson, S. Waters, 1984, Journal of neurochemistry.

Dexamethasone inhibits human interleukin 2 but not interleukin 2 receptor gene expression in vitro at the level of nuclear transcription.

D. Nelson, D. Boumpas, J. Balow, 1991, The Journal of clinical investigation.

In vivo T cell preactivation in chronic uremic hemodialyzed and non-hemodialyzed patients.

L. Chatenoud, P. Ureña, J. Bach, 1989, Kidney international.

The pathogenesis of gluten-sensitive enteropathy.

D. Nelson, H. Klaeveman, W. Strober, 1975, Annals of internal medicine.

Soluble interleukin-2 receptor level as an indicator of liver allograft rejection.

P. Grambsch, R. Krom, J. Rakela, 1989, Transplantation.

A secreted form of the human interleukin 2 receptor encoded by an "anchor minus" cDNA.

W. Leonard, W. Greene, B. Treiger, 1986, Journal of immunology.

Dissociation constants of serotonin agonists in the canine basilar artery correlate to Ki values at the 5-HT1A binding site.

D. Nelson, S. Duckles, E. W. Taylor, 1986, The Journal of pharmacology and experimental therapeutics.

In vitro and in vivo biochemistry of olanzapine: a novel, atypical antipsychotic drug.

D. Wong, F. Bymaster, D. Nelson, 1997, The Journal of clinical psychiatry.

X–linked lymphoproliferative syndrome

D. Nelson, C. Terhorst, D. Nelson, 2000, Clinical and experimental immunology.

Elevated levels of soluble interleukin-2 receptors in multiple sclerosis.

T. Waldmann, D. Nelson, S. Greenberg, 1988, The New England journal of medicine.

[3H]LY334370, a novel radioligand for the 5-HT1F receptor. II. Autoradiographic localization in rat, guinea pig, monkey and human brain

J. Krushinski, D. Nelson, J. Audia, 2005, Naunyn-Schmiedeberg's Archives of Pharmacology.

CD80 (B7.1) and CD54 (intracellular adhesion molecule-1) induce target cell susceptibility to promiscuous cytotoxic T cell lysis.

E. Podack, D. Nelson, J. Spielman, 1996, Journal of immunology.

Missense mutations of the WASP gene cause intermittent X-linked thrombocytopenia.

L. Notarangelo, H. Ochs, S. Giliani, 2002, Blood.

International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function

B. Roth, E. Lambe, M. Camilleri, 2020, Pharmacological Reviews.

Novel potent 5-HT(1F) receptor agonists: structure-activity studies of a series of substituted N-[3-(1-methyl-4-piperidinyl)-1H-pyrrolo[3,2-b]pyridin-5-yl]amides.

Kirk W. Johnson, T. Branchek, J. Zgombick, 2003, Journal of medicinal chemistry.

Molecular determinants for recognition of RU 24969 analogs at central 5-hydroxytryptamine recognition sites: use of a bilinear function and substituent volumes to describe steric fit.

D. Nelson, G. Lambert, A. Martin, 1988, Molecular pharmacology.

A novel (benzodifuranyl)aminoalkane with extremely potent activity at the 5-HT2A receptor.

D E Nichols, D. Nelson, D L Nelson, 1998, Journal of medicinal chemistry.

Dihydrobenzofuran analogues of hallucinogens. 3. Models of 4-substituted (2,5-dimethoxyphenyl)alkylamine derivatives with rigidified methoxy groups.

D. Nelson, M. Parker, D. B. Wainscott, 1996, Journal of medicinal chemistry.

Synthesis and evaluation of a novel series of N,N-dimethylisotryptamines.

R. Glennon, J. D. Mckenney, R. Young, 1984, Journal of medicinal chemistry.

Thieno[3,2-b]- and thieno[2,3-b]pyrrole bioisosteric analogues of the hallucinogen and serotonin agonist N,N-dimethyltryptamine.

D. Nelson, V. Lucaites, A. Kanthasamy, 1999, Journal of medicinal chemistry.

Potent, selective tetrahydro-beta-carboline antagonists of the serotonin 2B (5HT2B) contractile receptor in the rat stomach fundus.

D. Nelson, J. Audia, M. Cohen, 1996, Journal of medicinal chemistry.

LY367265, an inhibitor of the 5-hydroxytryptamine transporter and 5-hydroxytryptamine(2A) receptor antagonist: a comparison with the antidepressant, nefazodone.

D. Nelson, V. Lucaites, I. Pullar, 2000, European journal of pharmacology.

Design, synthesis and evaluation of bicyclic benzamides as novel 5-HT1F receptor agonists.

Sean R. Dinn, W. Gough, J. Krushinski, 2004, Bioorganic & medicinal chemistry letters.

N-[3-(2-Dimethylaminoethyl)-2-methyl-1H- indol-5-yl]-4-fluorobenzamide: a potent, selective, and orally active 5-HT(1F) receptor agonist potentially useful for migraine therapy.

J. Zgombick, D. Nelson, J. Audia, 2001, Journal of medicinal chemistry.

[3H]Metergoline: A New Ligand of Serotonin Receptors in the Rat Brain

A. Herbet, J. Glowinski, M. Hamon, 1981, Journal of Neurochemistry.

Distribution and properties of adrenergic storage vesicles in nerve terminals.

P. Molinoff, D. Nelson, 1976, The Journal of pharmacology and experimental therapeutics.

Adrenergic storage vesicles in rat heart: quantitation of membrane-bound and membrane-enclosed dopamine beta-hydroxylase.

P. Molinoff, T. K. Harden, D. Nelson, 1978, The Journal of pharmacology and experimental therapeutics.

Differential effects of nerve impulses on adrenergic storage vesicles in rat heart.

P. Molinoff, D. Nelson, 1976, The Journal of pharmacology and experimental therapeutics.

EFFECTS OF PHYSIOLOGICAL AND PHARMACOLOGICAL STRESS ON THE SUBCELLULAR DISTRIBUTION OF ADRENERGIC STORAGE VESICLES IN RAT HEART

P. Molinoff, D. Nelson, 1976 .

[3H]HARMALINE AS A SPECIFIC LIGAND OF MAO A—I. PROPERTIES OF THE ACTIVE SITE OF MAO A FROM RAT AND BOVINE BRAINS

A. Herbet, J. Glowinski, M. Hamon, 1979, Journal of neurochemistry.

Discrimination of Multiple [3H]5‐Hydroxytryptamine Binding Sites by the Neuroleptic Spiperone in Rat Brain

H. Yamamura, D. Nelson, D L Nelson, 1981, Journal of neurochemistry.

Ataxia-Telangiectasia: A Multisystem Hereditary Disease with Immunodeficiency, Impaired Organ Maturation, X-Ray Hypersensitivity, and a High Incidence of Neoplasia

T. Waldmann, K. Kraemer, D. Nelson, 1983 .

Molecular genetic analysis of the primary immunodeficiency disorders.

D. Nelson, C. Kurman, 1994, Pediatric clinics of North America.

Bacteremia and skin/bone infections in two patients with X-linked agammaglobulinemia caused by an unusual organism related to Flexispira/Helicobacter species.

D. Nelson, V. Gill, W. Strober, 2000, Clinical immunology.

In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis.

D. Nelson, E. Jones, W. Strober, 1977, The Journal of clinical investigation.

Studies of human leprosy lesions in situ using suction-induced blisters: cell changes with IgM antibody to PGL-1 and interleukin-2 receptor in clinical subgroups of erythema nodosum leprosum.

D. Nelson, D. Scollard, S. Chiewchanvit, 1991, Asian Pacific journal of allergy and immunology.

The soluble interleukin-2 receptor: biology, function, and clinical application.

L A Rubin, D. Nelson, D L Nelson, 1990, Annals of internal medicine.

Factors influencing serum neopterin and β2-microglobulin levels in a healthy diverse population

W. Blattner, L. Brown, D. Fuchs, 1994, Journal of Clinical Immunology.

Secretory component deficiency. A disorder of the IgA immune system.

D. Nelson, H. Klaeveman, H. Reynolds, 1976, The New England journal of medicine.

In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT(1B/1D/2) receptor antagonist properties.

J. Boot, D. Nelson, M. Cohen, 2001, European journal of pharmacology.

Fc receptors on human T lymphocytes: II. Cytotoxic capabilities of human Tγ, Tμ, B, and L cells

W. Pichler, D. Nelson, F. W. Gendelman, 1979 .

Fc receptors on human T-lymphocytes. III. Characterization of subpopulations involved in cell-mediated lympholysis and antibody-dependent cellular cytotoxicity.

W. Pichler, D. Nelson, S. Shaw, 1979, Journal of immunology.

The effector cells in human peripheral blood mediating mitogen-induced cellular cytotoxicity and antibody-dependent cellular cytotoxicity.

R. Blaese, D. Nelson, W. Strober, 1976, Journal of immunology.

The nature of the effector cells mediating mitogen-induced cellular cytotoxicity (MICC) and antibody-dependent cellular cytotoxicity (ADCC).

D. Nelson, W. Strober, B. M. Bundy, 1976, Cellular immunology.

R-fluoxetine Increases Extracellular DA, NE, As Well As 5-HT in Rat Prefrontal Cortex and Hypothalamus: An in vivo Microdialysis and Receptor Binding Study

K. Perry, F. Bymaster, D. Nelson, 2002, Neuropsychopharmacology.

Tetracaine blocks the responses of isolated acinar cells from rat parotid to carbachol but not to substance P.

D. Nelson, B. Miller, F. Butcher, 1979, Biochimica et biophysica acta.

Serotonin-sensitive adenylate cyclase and [3]serotonin binding sites in the CNS of the rat—I: Kinetic parameters and pharmacological properties

A. Herbet, J. Bockaert, M. Hamon, 1980 .

Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat.

A. Herbet, J. Glowinski, M. Hamon, 1978, Molecular pharmacology.

Pharmacological characterization of enantiomers of 8‐thiomethyl‐2‐(di‐n‐propylamino)tetralin, potent and selective 5‐HT1A receptor agonists

J. Barrett, D. Wong, R. Fuller, 1995 .

Immunomodulatory properties and toxicity of interleukin 2 in patients with cancer.

D. Longo, W. Urba, J. Clark, 1990, Cancer research.

Release of soluble interleukin-2 receptors (Tac peptide) in vivo during human immune responses to tuberculin.

D. Nelson, D. Scollard, D. Wagner, 1988, Clinical immunology and immunopathology.

Parameters affecting the development of non-Hodgkin's lymphoma in patients with severe human immunodeficiency virus infection receiving antiretroviral therapy.

D. Venzon, S. Broder, J. Karp, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Calcium fluxes in isolated acinar cells from rat parotid. Effect of adrenergic and cholinergic stimulation.

D. Nelson, B. Miller, 1977, The Journal of biological chemistry.

Novel [(diazomethyl)carbonyl]-1,2,3,4-tetrahydronaphthalene derivatives as potential photoaffinity ligands for the 5-HT1A receptor.

D. Nelson, K. Namboodiri, T. Kline, 1990, Journal of medicinal chemistry.

Intrinsic activity of enantiomers of 8-hydroxy-2-(di-n-propylamino)tetralin and its analogs at 5-hydroxytryptamine1A receptors that are negatively coupled to adenylate cyclase.

L. Arvidsson, U. Hacksell, C. Mellin, 1991, Molecular pharmacology.

Selective histamine H3 receptor antagonists for treatment of cognitive deficiencies and other disorders of the central nervous system.

J. Witkin, D. Nelson, 2004, Pharmacology & therapeutics.

A case of X-linked agammaglobulinemia diagnosed in adulthood.

D. Nelson, D. Stewart, L. Tian, 2001, Clinical immunology.

Cdc42-interacting Protein 4 Mediates Binding of the Wiskott-Aldrich Syndrome Protein to Microtubules*

D. Nelson, D. Stewart, L. Tian, 2000, The Journal of Biological Chemistry.

The thrombocytopenia of Wiskott Aldrich syndrome is not related to a defect in proplatelet formation.

A. Fischer, D. Nelson, E. Haddad, 1999, Blood.

Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation.

Silvia Giliani, Yinzhu Jin, Luigi D Notarangelo, 2004, Blood.

Direct inhibition of Bruton's tyrosine kinase by IBtk, a Btk-binding protein

R. Rabin, C. Palmieri, D. Nelson, 2001, Nature Immunology.

Serum and urine soluble interleukin-2 receptor in idiopathic nephrotic syndrome

D. Nelson, L. Patterson, G. Bock, 1993, Pediatric Nephrology.

The clinical spectrum of bruton’s agammaglobulinemia

D. Nelson, D. Stewart, L. Tian, 2001, Current allergy and asthma reports.

Molecular Cloning of ILP-2, a Novel Member of the Inhibitor of Apoptosis Protein Family

Stephanie Birkey Reffey, L. Notarangelo, S. Frank, 2001, Molecular and Cellular Biology.

A study of the functional capabilities of human neonatal lymphocytes for in vitro specific antibody production.

D. Nelson, R. Yarchoan, 1983, Journal of immunology.

Biochemistry and Pharmacology of the 5-HT1 Serotonin Binding Sites

D. Nelson, 1988 .

Serum-soluble interleukin-2 receptor levels in Kawasaki disease.

E. Silverman, D. Nelson, R. Laxer, 1990, The Journal of pediatrics.

Activation and Functional Capacity of Neonatal T Cells: Analysis of Interleukin-2 and Interleukin-2 Receptor Responsiveness

D. Nelson, 1987 .

The released interleukin 2 receptor binds interleukin 2 efficiently.

G. Jay, D. Nelson, L. Rubin, 1986, Journal of immunology.

Serum soluble IL-2 receptor as a tumor marker in patients with hairy cell leukemia

Jeffrey W. Clark, D. Longo, W. Urba, 1988 .

Serum soluble IL-2 receptor as a tumor marker in patients with hairy cell leukemia.

D. Longo, W. Urba, J. Clark, 1988, Blood.

Species differences in 5-HT2A receptors: cloned pig and rhesus monkey 5-HT2A receptors reveal conserved transmembrane homology to the human rather than rat sequence.

D. Nelson, M. Baez, M. P. Johnson, 1995, Biochimica et biophysica acta.

Molecular cloning, functional expression, and mRNA tissue distribution of the human 5-hydroxytryptamine2B receptor.

D. Nelson, M. Baez, D. B. Wainscott, 1994, Molecular pharmacology.

Spiroxatrine: a selective serotonin1A receptor antagonist.

D. Nelson, E. W. Taylor, 1986, European journal of pharmacology.

Identification of Regions of the Wiskott-Aldrich Syndrome Protein Responsible for Association with Selected Src Homology 3 Domains*

P. Finan, J. Hsuan, D. Nelson, 1996, The Journal of Biological Chemistry.

Choroid plexus protects cerebrospinal fluid against toxic metals

Wei Zheng, Wei Zheng, D. Nelson, 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor.

D. Nelson, J. Audia, M. Cohen, 1993, Molecular pharmacology.

Second-site mutation in the Wiskott-Aldrich syndrome (WAS) protein gene causes somatic mosaicism in two WAS siblings.

F. Candotti, S. Schurman, S. Anderson, 2003, The Journal of clinical investigation.

Mutations that cause the Wiskott-Aldrich syndrome impair the interaction of Wiskott-Aldrich syndrome protein (WASP) with WASP interacting protein.

D. Nelson, D. Stewart, L. Tian, 1999, Journal of immunology.

Confirming or Excluding the Diagnosis of Wiskott-Aldrich Syndrome in Children With Thrombocytopenia of an Unknown Etiology

T. Ariga, Y. Sakiyama, D. Nelson, 2004, Journal of pediatric hematology/oncology.

Defective specific antiinfluenza virus antibody production in vitro by lymphocytes from patients with ataxia-telangiectasia.

D. Nelson, R. Yarchoan, C. Kurman, 1985, Kroc Foundation series.

Selective IgA deficiency associated with total villous atrophy of the small intestine and an organ-specific anti-epithelial cell antibody.

T. Waldmann, D. Nelson, D. McCarthy, 1978, Journal of immunology.

Blood Mononuclear Cells Syndrome Protein Expression in Peripheral Cytometric Analysis of Wiskott-Aldrich Wiskott-Aldrich Syndrome by Flow Determination of Carrier Status for the Kobayashi and Yukio

M. Yamada, I. Kobayashi, T. Ariga, 2000 .

Defective actin polymerization in EBV‐transformed B‐cell lines from patients with the Wiskott–Aldrich syndrome

L. Notarangelo, S. Giliani, W. Vermi, 1998, The Journal of pathology.

Mixed chimera status of 12 patients with Wiskott-Aldrich syndrome (WAS) after hematopoietic stem cell transplantation: evaluation by flow cytometric analysis of intracellular WAS protein expression.

Yasuhiko Ito, M. Yamada, T. Ariga, 2002, Blood.

Syndrome Inherited Mutation in the Wiskott-Aldrich Spontaneous In Vivo Reversion of an Sakiyama

M. Yamada, T. Ariga, Kunihiko Kobayashi, 2001 .

Development of fluorine-18-labeled 5-HT1A antagonists.

W C Eckelman, R E Carson, E Jagoda, 1999, Journal of medicinal chemistry.

Release of sIL-2R alpha from and activation of native human peripheral blood mononuclear cells by recombinant IL-15.

D. Nelson, C. Kurman, D. Stewart, 1996, Clinical immunology and immunopathology.

Racial variation in serum-soluble interleukin-2 receptor levels: a population-based study of healthy smokers and nonsmokers.

W. Blattner, L. Brown, D. Nelson, 1994, Clinical immunology and immunopathology.

Human cytotoxic response in vitro to trinitrophenyl-modified autologous cells. I. T cell recognition of TNP in association with widely shared antigens.

G. Shearer, D. Nelson, S. Shaw, 1978, Journal of immunology.

Interleukin 2 receptor expression by T cells in human aging.

F. Orson, F. Orson, D. Nelson, 1989, Cellular immunology.

Antibody-dependent cellular cytotoxicity effector cells lack Ia antigens.

D. Sachs, D. Nelson, H. Dickler, 1977, Journal of immunology.

A reappraisal of the effector cells mediating mitogen induced cellular cytotoxicity.

H. Kirchner, A. Muchmore, R. Blaese, 1975, Cellular Immunology.

Cellular source of soluble interleukin 2 receptors in serum of mice after recombinant interleukin 2 administration.

M. Gately, D. Nelson, H. Wong, 1990, Cytokine.

Olanzapine: a basic science update

D. Wong, K. Perry, F. Bymaster, 1999, British Journal of Psychiatry.

Antigen-specific murine T cell clones produce soluble interleukin 2 receptor on stimulation with specific antigens.

J. Berzofsky, T. Malek, D. Nelson, 1986, Journal of immunology.

Antigen-stimulated human B cell clones are committed to the production of a single class of antibody in vitro.

D. Nelson, R. Yarchoan, C. Kurman, 1984, Journal of immunology.

Antagonism by olanzapine of dopamine D1, serotonin2, muscarinic, histamine H1 and α 1-adrenergic receptors in vitro

F. Bymaster, D. Nelson, N. Delapp, 1999, Schizophrenia Research.

Levels of soluble interleukin-2 receptors are predictive of response in patients treated with interleukin-2 and lymphokine-activated killer cells

J. Dutcher, E. Paietta, D. Nelson, 1995, Medical oncology.

Resolved N,N-dialkylated 2-amino-8-hydroxytetralins: stereoselective interactions with 5-HT1A receptors in the brain.

N. Andén, U. Hacksell, D. Nelson, 1989, Journal of medicinal chemistry.

Serotonergic properties of spiroxatrine enantiomers.

D. Nelson, S S Nikam, A R Martin, 1988, Journal of medicinal chemistry.

Central dopaminergic and 5-hydroxytryptaminergic effects of C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin.

N. Andén, U. Hacksell, C. Mellin, 1988, Journal of medicinal chemistry.

Relative selectivity of some conformationally constrained tryptamine analogs at 5-HT1, 5-HT1A and 5-HT2 recognition sites.

D. Nelson, A. Martin, S. Nikam, 1987, Life sciences.

Serotonin-receptors coupled with an adenylate cyclase in the rat brain: non-identity with 3H-5-HT binding sites.

A. Herbet, J. Bockaert, M. Hamon, 1981, Advances in experimental medicine and biology.

Comparative Affinity of Duloxetine and Venlafaxine for Serotonin and Norepinephrine Transporters in vitro and in vivo, Human Serotonin Receptor Subtypes, and Other Neuronal Receptors

D. Wong, F. Bymaster, L. Thompson, 2001, Neuropsychopharmacology.

Chronic AMPA receptor potentiator (LY451646) treatment increases cell proliferation in adult rat hippocampus

M. Bergeron, D. Nelson, F. Bai, 2003, Neuropharmacology.

An Allosteric Potentiator of the Dopamine D1 Receptor Increases Locomotor Activity in Human D1 Knock-In Mice without Causing Stereotypy or Tachyphylaxis

Todd R. Wiernicki, Charles R. Yang, T. Suter, 2017, The Journal of Pharmacology and Experimental Therapeutics.

Are 5-HT receptors involved in the sprouting of serotoninergic terminals following neonatal 5,7-dihydroxytryptamine treatment in the rat?

M. Hamon, D. Nelson, M. Mallat, 1981, Neurochemistry International.

[3H]HARMALINE AS A SPECIFIC LIGAND OF MAO A–II. MEASUREMENT OF THE TURNOVER RATES OF MAO A DURING ONTOGENESIS IN THE RAT BRAIN

A. Herbet, J. Glowinski, M. Hamon, 1979, Journal of neurochemistry.

Characterization of 5-HT1A receptor-mediated [35S]GTPgammaS binding in rat hippocampal membranes.

D. Nelson, R. Alper, David L. Nelson, 1998, European journal of pharmacology.

Reconstitution of a functional interleukin 2 receptor in a nonlymphoid cell.

W. Greene, G. Jay, D. Nelson, 1987, Journal of Immunology.

Receptor subtype and density determine the coupling repertoire of the 5-HT2 receptor subfamily.

D. Nelson, M. Baez, V. Lucaites, 1996, Life sciences.

Lu AE58054, a 5-HT6 antagonist, reverses cognitive impairment induced by subchronic phencyclidine in a novel object recognition test in rats.

Ben Grayson, John M Schaus, F. Bymaster, 2010, The international journal of neuropsychopharmacology.

Elevated serum levels of soluble interleukin-2 receptors in active pulmonary sarcoidosis: relative specificity and association with hypercalcemia.

D. Nelson, C. Kurman, E. C. Lawrence, 1987, Sarcoidosis.

5-HT5 receptors.

D. Nelson, D L Nelson, 2004, Current drug targets. CNS and neurological disorders.

Molecular cloning and pharmacological characterization of the guinea pig 5-HT1E receptor.

D. Nelson, S. Little, G. Varga, 2004, European journal of pharmacology.

Indoloxypropanolamine analogues as 5-HT(1A) receptor antagonists.

John M Schaus, D. Wong, J. Krushinski, 2007, Bioorganic & medicinal chemistry letters.

Production of human suppressor T cell hybridomas.

T. Waldmann, W. Greene, D. Nelson, 1982, Journal of immunology.

Pharmacological profile of LY301317, a potent and selective 5‐HT1A agonist

J. Gidda, R. Fuller, S. Hemrick-Luecke, 1997 .

In vitro and in vivo disposition of 3H-methiothepin in brain tissues

A. Herbet, J. Glowinski, M. Hamon, 1979, Naunyn-Schmiedeberg's Archives of Pharmacology.

A Nucleoside Diphosphate Kinase from Paramecium tetraurelia with Protein Kinase Activity

D. Nelson, D. Nelson, K. Ann, 1996, The Journal of eukaryotic microbiology.

Paramecium Has Two Regulatory Subunits of Cyclic AMP‐Dependent Protein Kinase, One Unique to Cilia

D. Nelson, C. Walczak, M. Hochstrasser, 1996, The Journal of eukaryotic microbiology.

Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects.

N. Andén, T. Lewander, U. Hacksell, 1991, The Journal of pharmacology and experimental therapeutics.

MODIFICATIONS OF ANTI-Fab IMMUNOABSORBENT SEPARATION OF HUMAN PERIPHERAL BLOOD MONONUCLEAR CELLS

R. Macdermott, D. Nelson, 1977 .

Serotonin-sensitive adenylate cyclase and [3H]serotonin binding sites in the CNS of the rat--II. Respective regional and subcellular distributions and ontogenetic developments.

A. Herbet, J. Bockaert, M. Hamon, 1980, Biochemical pharmacology.

Serial levels of soluble interleukin 2 receptor in the peripheral blood of patients with rheumatoid arthritis: correlations with disease activity.

E. Keystone, D. Nelson, L. Rubin, 1990, The Journal of rheumatology.

Comparison of two different arterial tissues suggests possible 5-hydroxytryptamine2 receptor heterogeneity.

D. Nelson, G. Lambert, A. Martin, 1990, The Journal of pharmacology and experimental therapeutics.

MDL 73005EF: partial agonist at the 5-HT1A receptor negatively linked to adenylate cyclase.

D. Nelson, E. Taylor, A. Martin, 1989, European journal of pharmacology.

Molecular cloning, functional expression, and pharmacological characterization of a novel serotonin receptor (5-hydroxytryptamine2F) from rat stomach fundus.

D. Nelson, M. Cohen, M. Baez, 1992, Molecular pharmacology.

Pharmacologic characterization of the human 5-hydroxytryptamine2B receptor: evidence for species differences.

D. Nelson, M. Baez, V. Lucaites, 1996, The Journal of pharmacology and experimental therapeutics.

Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, 5-HT2B and 5-HT2C receptors

R. Glennon, D. Nelson, V. Lucaites, 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

LY215840, a high-affinity 5-HT7 receptor ligand, blocks serotonin-induced relaxation in canine coronary artery.

J. Zgombick, D. Nelson, M. Cohen, 1996, The Journal of pharmacology and experimental therapeutics.

m-CPP hypolocomotion is selectively antagonized by compounds with high affinity for 5-HT2C receptors but not 5-HT2A or 5-HT2B receptors

D. Nelson, H. Shannon, V. Lucaites, 2001, Behavioural pharmacology.

Characterization of LY344864 as a pharmacological tool to study 5-HT1F receptors: binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraine.

T. Branchek, J. Zgombick, P. Gilbert, 1997, Life sciences.

Inactivation of 5-HT(1A) receptors in hippocampal and cortical homogenates.

D. Nelson, R. Alper, 2000, European journal of pharmacology.

Human 5-HT1F receptor-stimulated [35S]GTPgammaS binding: correlation with inhibition of guinea pig dural plasma protein extravasation.

D. Nelson, L. Phebus, K. Johnson, 1998, European journal of pharmacology.

Characterization of a [3H]-5-hydroxytryptamine binding site in rabbit caudate nucleus that differs from the 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D subtypes.

D. Nelson, W. Xiong, 1989, Life sciences.

B lymphocytes from individuals with common variable immunodeficiency respond to B lymphocyte stimulator (BLyS protein) in vitro.

D. Hilbert, D. Nelson, D. Stewart, 2003, Clinical immunology.

Serotonin-sensitive adenylate cyclase and [3H]serotonin binding sites in the CNS of the rat--I.

A. Herbet, J. Bockaert, M. Hamon, 1980, Biochemical pharmacology.

Molecular biology of serotonin receptors.

L. Helton, D. Nelson, M. Baez, 1995, Obesity research.

Specificity of in vitro anti-influenza virus antibody production by human lymphocytes: analysis of original antigenic sin by limiting dilution cultures.

D. Nelson, R. Yarchoan, 1984, Journal of immunology.

Specific anti-influenza virus antibody production in vitro by human peripheral blood mononuclear cells.

B. Murphy, D. Nelson, R. Yarchoan, 1981, Journal of immunology.

Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency

C. Cunningham-Rundles, Likun Du, Q. Pan-Hammarström, 2007, Nature Genetics.

Molecular genetic analysis of X-linked hypogammaglobulinemia and isolated growth hormone deficiency.

L. Staudt, D. Nelson, L. Notarangelo, 1995, Journal of immunology.

Regulatory properties of neuronal tryptophan hydroxylase.

F. Artaud, M. Hamon, D. Nelson, 1981, Advances in experimental medicine and biology.

Update on X-linked hypogammaglobulinemia with isolated growth hormone deficiency

L. Notarangelo, D. Nelson, D. Stewart, 2005, Current opinion in allergy and clinical immunology.

The 44‐kDa Regulatory Subunit of the Paramecium cAMP‐Dependent Protein Kinase Lacks a Dimerization Domain and May Have a Unique Autophosphorylation Site Sequence

D. Nelson, D. Nelson, G. Carlson, 1996, The Journal of eukaryotic microbiology.

Human peripheral blood mononuclear cells produce IgA anti-influenza virus antibody in a secondary in vitro antibody response.

D. Nelson, R. Yarchoan, W. Strober, 1985, Journal of Immunology.

Elevated levels of soluble interleukin 2 receptors in schizophrenia.

S. Paul, D. Pickar, D. Nelson, 1989, Archives of general psychiatry.

Configuring radioligand receptor binding assays for HTS using scintillation proximity assay technology.

P. Johnston, D. Nelson, D. Mcclure, 2002, Methods in molecular biology.

Immunologic characteristics of intestinal lymphoid cells of the guinea pig.

D. Nelson, F. Arnaud-Battandier, Franck Arnaud-Battandier, 1982, Gastroenterology.

Structure-activity relationships at 5-HT1A receptors: Binding profiles and intrinsic activity

D. Nelson, 1991, Pharmacology Biochemistry and Behavior.

In Vitro and in Vivo Evidence for a Lack of Interaction with Dopamine D2 Receptors by the Metabotropic Glutamate 2/3 Receptor Agonists 1S,2S,5R,6S-2-Aminobicyclo[3.1.0]hexane-2,6-bicaroxylate Monohydrate (LY354740) and (−)-2-Oxa-4-aminobicyclo[3.1.0] Hexane-4,6-dicarboxylic Acid (LY379268)

G. Marek, K. Perry, D. McKinzie, 2009, Journal of Pharmacology and Experimental Therapeutics.

DOI and alpha-methylserotonin: comparative vascular and nonvascular smooth muscle effects and central 5-hydroxytryptamine2 receptor affinities.

D. Robertson, D. Nelson, M. Cohen, 1993, Journal of Pharmacology and Experimental Therapeutics.

Serum soluble interleukin-2 receptor (IL-2R) in children with allersic disorders

J. Bellanti, F. Candotti, D. Nelson, 2014 .

Soluble interleukin 2 receptor level in liver allograft recipients: an indicator of rejection.

P. Grambsch, J. Rakela, D. Nelson, 1989, Transplantation proceedings.

Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 1.

D. Wong, K. Takeuchi, D. Nelson, 2003, Bioorganic & medicinal chemistry letters.

Advances Toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT(1A) receptor antagonism/SSRI activities. Part 2.

D. Wong, L. Hertel, K. Takeuchi, 2003, Bioorganic & medicinal chemistry letters.

The Production of Soluble and Cellular Interleukin-2 Receptors by Cord Blood Mononuclear Cells following In Vitro Activation

D. Nelson, L. Rubin, C. Kurman, 1986, Pediatric Research.

Defective in vitro production of influenza virus-specific cytotoxic T lymphocytes in ataxia-telangiectasia.

D. Nelson, W. Biddison, S. Shaw, 1983, Journal of immunology.

Soluble interleukin 2 receptor level in liver allograft recipients

P. Grambsch, J. Rakela, D. Nelson, 1989 .

Changes in Health for Patients Who Complete Treatment for Chronic Hepatitis C Virus -- The PROP up TARGET Study

B. Reeve, A. Lok, C. Golin, 2020 .

Preclinical studies on LY228729: a potent and selective serotonin1A agonist.

D. Wong, R. Fuller, D. Nelson, 1993, The Journal of pharmacology and experimental therapeutics.

Elevated soluble interleukin-2 receptor levels early after heart transplantation and long-term survival and development of coronary arteriopathy.

N. Kleiman, D. Nelson, J. Young, 1991, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Regulation and Function of WASp in Platelets by the Collagen Receptor, Glycoprotein VI

S. Watson, D. Nelson, H. Chapel, 1999 .

HEMOSTASIS , THROMBOSIS , AND VASCULAR BIOLOGY Regulation and Function of WASp in Platelets by the Collagen Receptor , Glycoprotein

D. Nelson, H. Chapel, J. Wilde, 1999 .

[3H]spiroxatrine labels a serotonin1A-like site in the rat hippocampus.

H. Yamamura, D. Nelson, G. Lambert, 1987, Life Science.

Induction and Measurement of In Vivo Antibody Responses

D. Nelson, C. Kurman, R. Engler, 1991, Current protocols in immunology.

Regulation and Function of WASp in Platelets by the Collagen Receptor, Glycoprotein VI

S. Watson, D. Nelson, H. Chapel, 1999 .

Discovery of selective N-[3-(1-methyl-piperidine-4-carbonyl)-phenyl]-benzamide-based 5-HT₁ F receptor agonists: Evolution from bicyclic to monocyclic cores.

John M Schaus, Maria-Jesus Blanco, Joseph Krushinski, 2015, Bioorganic & medicinal chemistry letters.

Possible application of flow cytometry for evaluation of the structure and functional status of WASP in peripheral blood mononuclear cells

M. Yamada, T. Ariga, Y. Sakiyama, 2009, European journal of haematology.

The cytotoxic effector potential of some common non-lymphoid tumors and cultured cell lines with phytohemagglutinin and heterologous anti-erythrocyte antisera.

A. Muchmore, R. Blaese, D. Nelson, 1975, Journal of immunology.

Pharmacological characterization of LY293284: A 5-HT1A receptor agonist with high potency and selectivity.

R. Fuller, D. Nelson, K. Rasmussen, 1994, The Journal of pharmacology and experimental therapeutics.

Partial immune reconstitution of X-linked hyper IgM syndrome with recombinant CD40 ligand.

S. Pittaluga, H. Ochs, S. Migueles, 2011, Blood.

m-CPP hypolocomotion is selectively antagonized by compounds with high affinity for 5-HT receptors but not

D. Nelson, H. Shannon, V. Lucaites, 2001 .

Central serotonergic receptors: Evidence for heterogeneity and characterization by ligand-binding

D. Nelson, 1982, Neuroscience & Biobehavioral Reviews.